Skip to main content
MASIMO CORP logo

MASIMO CORP — Investor Relations & Filings

Ticker · MASI ISIN · US5747951003 LEI · 549300Q4A8JK0PIYCU29 US Manufacturing
Open in API
Filings indexed 1,253 across all filing types
Latest filing 2017-05-24 Remuneration Information
Country US United States of America
Listing US MASI

About MASIMO CORP

https://www.masimo.com/

Masimo is a global medical technology company that develops, manufactures, and markets a wide array of noninvasive patient monitoring technologies. The company's core offering is its proprietary Signal Extraction Technology (SET®) pulse oximetry, renowned for its ability to provide accurate measurements during patient motion and low peripheral perfusion. Masimo's product portfolio also includes advanced solutions for brain function monitoring (SedLine®), regional oximetry (O3®), and integrated patient monitoring and connectivity platforms like Root®. These technologies are designed to improve patient outcomes, enhance patient safety, and streamline clinical workflows in various healthcare settings, including hospitals, emergency medical services, and home care. The company focuses on creating innovative solutions that empower clinicians with reliable data to make critical care decisions.

Recent filings

Filing Released Lang Actions
DEFA14A
Remuneration Information Classification · 100% confidence The document is titled 'SCHEDULE 14A INFORMATION' and is a 'Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934.' It is a supplement to the proxy statement for the Annual Meeting of Stockholders of Masimo Corporation, dated May 24, 2017. The content corrects information related to voting shares and quorum requirements for the Annual Meeting. It discusses voting procedures, record dates, and proxy submission details. This type of document is clearly related to proxy solicitation and information provided to shareholders to facilitate voting at the Annual Meeting. It is not the Annual Report itself, nor an announcement of voting results, but rather additional materials supplementing the proxy statement. Therefore, the correct classification is 'DEF 14A' which covers remuneration and proxy solicitation information statements.
2017-05-24 English
FORM 4
Director's Dealing
2017-05-10 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The text specifically mentions Item 7.01 Regulation FD Disclosure, which relates to the furnishing of presentation slides from an Investor Day event. The document states that the slides are posted on the company's website and that the information is being furnished, not filed, and is not incorporated by reference into other filings. There is no substantive financial data or detailed financial report included in the text; rather, it is an announcement of the availability of investor presentation materials. According to the classification rules, such a document is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement and does not contain the full investor presentation itself, only a notice about it. The document length (6698 characters) is moderate but the content is clearly an 8-K current report furnishing information rather than the report itself.
2017-05-09 English
10-Q
Interim / Quarterly Report Q1 2017
2017-05-03 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated May 3, 2017, reporting the financial results for the quarter ended April 1, 2017. It specifically mentions that a press release announcing the quarterly financial results is attached as Exhibit 99.1. The text indicates this is a current report announcing quarterly financial results, which aligns with an Earnings Release (ER). The document length is 3932 characters, which is relatively short but contains the actual announcement of quarterly results, not just a notice of report publication. Therefore, it is classified as an Earnings Release (ER).
2017-05-03 English
FORM 4
Director's Dealing
2017-05-01 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.